Brocher NAAC

Courses Offered

• MBBS
• MD
• PhD
• M.Sc. (Medical Biochemistry)

CCL Biochemistry Test List

SR. NO	TEST
1	ABG
2	ADA MTB
3	AFP Alpha Protein
4	Albumin
5	Alkaline Phosphatase
6	Amylase
7	Anti TPO
8	Beta HCG
9	Blood Urea
10	Blood Urea Nitrogen (BUN)
11	BSL Fasting
12	BSL PP
13	BSL PP2
14	BSL Random
15	Calcium
16	Carcino Embryonic Antigen (CEA)
17	Chloride
18	Cholesterol
19	CKMB
20	Cortisol
21	C-Peptide
22	CPK
23	Creatinine
24	CRP HS
25	DHEA-S
26	Direct Bilirubin
27	Electrolyte
28	Estradiol
29	Ferritin
30	Folate
31	Free T3
32	Free T4
33	TSH
34	FSH
35	FSH-LH-PRL
36	GTT
37	HBA1C
38	HDL-C
39	Insulin
40	Ionic Calcium
41	Iron
42	Iron Study (Ferritin+Iron)
43	Lactate
44	LDH
45	Ldl Low Lipoprotein
46	LFT
47	LH
48	Lipase
49	Lipid Profile (FLP)
50	Lithium
51	Magnesium
52	Micro Albumin
53	Phosphorus
54	Prolactin
55	PSA
56	PTH
57	Renal Tests
58	Serum Osmolarity
59	Serum Protein + Albumin
60	Serum Protein
61	SGOT
62	SGPT
63	T3
64	T3+T4+TSH
65	T4
66	Tacrolimus
67	Testosterone
68	Total Bilirubin
69	TPO Antibody
70	Triglycerides
71	Trop I
72	Trop-T
73	TSH
74	Uric Acid
75	Urinary Amylase
76	Urinary Calcium
77	Urinary Potassium
78	Urine Albumin Creatinine Ratio
79	Urine Osmolality
80	Urine Phosphorus
81	Urine Protein Creatinine Ratio (UPCR)
82	Urine Protein for 24 Hrs
83	24 Hrs Urine Sodium
84	24 Hrs Urine Creatinine
85	Spot Urine Protein
86	Spot Urine Sodium
87	Spot Urine Creatinine
88	Urine Electrolytes
89	Urobilinogen
90	Valproic Acid
91	VBG
92	Ammonia
93	Vitamin B12
94	Vitamin D3
95	Homocysteine
96	Serum Electrophoresis
97	HB Electrophoresis
98	Xylose Excretion
99	Fluid LDH
100	Fluid Amylase
101	Fluid Albumin
102	Fluid Lipase
103	Fluid Creatinine

SN	Name of the Faculty	Photograph	Educational Qualification	Designation	Registration No.
1	Dr. Pradnya Jay Phalak		MBBS, MD	Professor & HOD	2003031057
2	Dr. Umesh Kishanrao More		MSc, PhD (Medical Biochemistry)	Professor	NA
3	Dr. Sarita Anil Shinde		MSc, PhD (Medical Biochemistry)	Professor	NA
4	Dr. Abhijit Pratap		MBBS, MD	Professor	2009072811
5	Dr. Anita Deepak Deshmukh		MBBS, MD	Associate Professor	73993
6	Dr. Arti Mihir Hajarnavis		MSc, PhD (Medical Biochemistry)	Associate Professor	NA
7	Dr. Vrushali Anupkumar Rawool		MBBS, MD	Associate Professor	2005042209
8	Dr. Sandesh Gorakh Thorat		MBBS, MD	Associate Professor	2004103644
9	Dr. Madhuri Abhay Jagtap		MSc, PhD (Medical Biochemistry)	Assistant Professor	NA
10	Dr. Mohana Kumari C		MBBS, MD	Assistant Professor	94787
11	Mrs. Nidhi Rohan Purandare		MSc (Medical Biochemistry)	Tutor	NA
12	Dr. Astha Goyal		BDS, MSc, PhD (Medical Biochemistry)	Tutor	NA
13	Mrs. Meenakshi		BMLT, MSc (Medical Biochemistry)	Tutor	NA
14	Dr. Aiswarya Thankam Roy		MBBS	Tutor	2021043413
15	Dr. Saniya Rajjak Sayyad		MBBS	Tutor	2019064580
16	Dr. Vinod Kumar P		MBBS	Tutor	PR 20240044631
17	Dr. Pritam Bhaskar Mhase		MBBS	Tutor	188134
18	Dr. Viraj Babasaheb Choure		MBBS	Tutor	2023020432

Staff Accommodation

Extension & Outreach

• 2014 2014
• 2015 2015
• 2016 2016
• 2017 2017
• 2018 2018
• 2019 2019
• 2020 2020
• 2021 2021
• 2022 2022
• 2023 2023
• 2024 2024

1. Atherosclerosis: Research Reveals New Mechanism and Therapeutic Target

   New research offers fresh insights into how a type of immune cell can destabilize the fatty deposits, or plaques, that form in arteries during atherosclerosis. Healthy arteries keep the heart healthy. A new study may help prevent atherosclerosis — a disease that affects our blood vessels.

   Atherosclerosis is a persistent, inflammatory condition in which plaques build up inside arteries, causing them to narrow and restrict blood flow. When an atherosclerotic plaque bursts or breaks, it can trigger a heart attack or stroke.

   Neutrophils are an abundant type of leukocyte (white blood cell) that defend against infection by attacking microbes. They also serve "many roles in inflammation." The new international study reveals that neutrophils can aggravate atherosclerosis by triggering a previously unknown type of cell death that destabilizes arterial plaques.

   A recent Nature paper describes how neutrophils can induce a series of molecular events that also kills the smooth muscle cells that help to retain the plaques in the artery wall. "Every inflammatory reaction," says co-corresponding study author Prof. Oliver Söhnlein, from the Institute for Cardiovascular Prevention at the Ludwig Maximilian University (LMU) of Munich in Germany, "results in some collateral damage, because neutrophils also attack healthy cells."

   He and his colleagues have also designed and made a "tailored peptide" that could potentially target and block the cell-death process.

2. Embryo Stem Cells Created from Skin Cells

   Researchers at the Hebrew University of Jerusalem (HU) have found a way to transform skin cells into the three major stem cell types that comprise early-stage embryos. The work (in mouse cells) has significant implications for modelling embryonic disease and placental dysfunctions, as well as paving the way to create whole embryos from skin cells.

   As published in Cell Stem Cell, Dr. Yossi Buganim of HU's Department of Developmental Biology and Cancer Research and his team discovered a set of genes capable of transforming murine skin cells into all three of the cell types that comprise the early embryo: the embryo itself, the placenta and the extra-embryonic tissues, such as the umbilical cord. In the future, it may be possible to create entire human embryos out of human skin cells, without the need for sperm or eggs. This discovery also has vast implications for modelling embryonic defects and shedding light on placental dysfunctions, as well as solving certain infertility problems by creating human embryos in a petri dish.

   Back in 2006, Japanese researchers discovered the capacity of skin cells to be "reprogrammed" into early embryonic cells that can generate an entire fetus, by expressing four central embryonic genes. These reprogrammed skin cells, termed "Induced Pluripotent Stem Cells" (iPSCs), are similar to cells that develop in the early days after fertilization and are essentially identical to their natural counterparts. These cells can develop into all fetal cell types, but not into extra-embryonic tissues, such as the placenta.

   Now, the Hebrew University research team, headed by Dr. Yossi Buganim, Dr. Oren Ram from the HU's Institute of Life Science and Professor Tommy Kaplan from HU's School of Computer Science and Engineering, as well as doctoral students Hani Benchetrit and Mohammad Jaber, found a new combination of five genes that, when inserted into skin cells, reprogram the cells into each of three early embryonic cell types -- iPS cells which create fetuses, placental stem cells, and stem cells that develop into other extra-embryonic tissues, such as the umbilical cord. These transformations take about one month.

   The HU team used new technology to scrutinize the molecular forces that govern cell fate decisions for skin cell reprogramming and the natural process of embryonic development. For example, the researchers discovered that the gene "Eomes" pushes the cell towards placental stem cell identity and placental development, while the "Esrrb" gene orchestrates fetus stem cells development through the temporary acquisition of an extra-embryonic stem cell identity.

   To uncover the molecular mechanisms that are activated during the formation of these various cell types, the researchers analyzed changes to the genome structure and function inside the cells when the five genes are introduced into the cell. They discovered that during the first stage, skin cells lose their cellular identity and then slowly acquire a new identity of one of the three early embryonic cell types, and that this process is governed by the levels of two of the five genes.

   Recently, attempts have been made to develop an entire mouse embryo without using sperm or egg cells. These attempts used the three early cell types isolated directly from a live, developing embryo. However, HU's study is the first attempt to create all three main cell lineages at once from skin cells. Further, these findings mean there may be no need to "sacrifice" a live embryo to create a test tube embryo.

3. End to Aids in Sight as Huge Study Finds Drugs Stop HIV Transmission

   An end to the Aids epidemic could be in sight after a landmark study found men whose HIV infection was fully suppressed by antiretroviral drugs had no chance of infecting their partner.

   The success of the medicine means that if everyone with HIV were fully treated, there would be no further infections.

   Among nearly 1,000 male couples across Europe where one partner with HIV was receiving treatment to suppress the virus, there were no cases of transmission of the infection to the HIV-negative partner during sex without a condom. Although 15 men were infected with HIV during the eight-year study, DNA testing proved that was through sex with someone other than their partner who was not on treatment.

   “It’s brilliant – fantastic. This very much puts this issue to bed,” said Prof Alison Rodger from University College London, the co-leader of the paper published in the Lancet medical journal. Earlier studies have also shown the treatment protects heterosexual couples where one partner has HIV.

   She added: “Our findings provide conclusive evidence for gay men that the risk of HIV transmission with suppressive ART [antiretroviral therapy] is zero. Our findings support the message of the international U=U campaign that an undetectable viral load makes HIV untransmittable.”

   “This powerful message can help end the HIV pandemic by preventing HIV transmission, and tackling the stigma and discrimination that many people with HIV face. Increased efforts must now focus on wider dissemination of this powerful message and ensuring that all HIV-positive people have access to testing, effective treatment, adherence support and linkage to care to help maintain an undetectable viral load.”

   In 2017, there were almost 40 million people worldwide living with HIV, of whom 7 million were on antiretroviral treatment. An estimated 101,600 people are living with HIV in the UK, and of these, about 7,800 are undiagnosed, so do not know they are HIV positive.

   Myron S Cohen of the UNC Institute for Global Health and Infectious Diseases at Chapel Hill in North Carolina, said in a commentary in the Lancet on the study that it should push the world forward on a strategy to test and treat everyone who has HIV. But, he added, maximising the benefits of treatment, particularly for men who have sex with men, has proved difficult.

   “It is not always easy for people to get tested for HIV or find access to care; in addition, fear, stigma, homophobia and other adverse social forces continue to compromise HIV treatment,” he said. “Diagnosis of HIV infection is difficult in the early stages of infection when transmission is very efficient, and this limitation also compromises the treatment as prevention strategy.”

   According to the National Aids Trust, 97% of people on HIV treatment in the UK have an undetectable level of the virus, meaning they cannot pass it on. “Hearing this can be enormously empowering and reassuring to people living with HIV,” said Deborah Gold, the trust’s chief executive.

   The latest findings reinforce the importance of people taking HIV tests frequently, which could ultimately end the transmission of the virus altogether in the future. New diagnoses have been declining since their peak in 2005, with figures from 2017 showing a 17% drop on 2016 and a 28% fall compared with 2015.

   Late diagnosis remains a major challenge, still accounting for about 43% of new HIV diagnoses. This disproportionately affects certain groups, including black African heterosexual men and people aged 65 and older.

   “If we don’t reduce late diagnosis, there will always be those who are not aware of their HIV status and who therefore cannot access treatment,” said Gold. “We think that the findings from this study could be incredibly powerful in breaking down some of the barriers to testing in communities where there is still a lot of stigma around HIV.”

   However, she added that government funding cuts to specialist health services would make it more difficult to achieve a goal of eliminating transmission by 2030.

   Jens Lundgren, a professor of infectious diseases at Rigshospitalet, University of Copenhagen, and joint-lead for the study, called Partner, said: “We have now provided the conclusive scientific evidence for how treatment effectively prevents further sexual transmission of HIV.”

   Dr Michael Brady, the medical director at the Terrence Higgins Trust, said: “It is impossible to overstate the importance of these findings. The Partner study has given us the confidence to say, without doubt, that people living with HIV who are on effective treatment cannot pass the virus on to their sexual partners. This has incredible impact on the lives of people living with HIV and is a powerful message to address HIV-related stigma.”

   Bruce Richman, the founding executive director of the Prevention Access Campaign, which launched U=U, said Pac was tremendously grateful to the researchers and participants. He said the study “has forever changed what it means to live and love with HIV around the world.”

   In a linked comment in the journal, Cohen expressed optimism for future treatment of Aids. “During the course of these studies, antiretroviral drugs have become more effective, reliable, durable, easier to take, well tolerated and much less expensive,” he said. “The results … provide yet one more catalyst for a universal test-and-treat strategy to provide the full benefits of antiretroviral drugs. This and other strategies continue to push us toward the end of Aids.”

   Case Study

   Alex Sparrowhawk, 34, has been living with HIV for almost 10 years. When he was diagnosed in November 2009, he had two major concerns: how being HIV positive would impact his work as a financial analyst, and what it meant for future relationships.

   “I was single at the time,” he said. “Just navigating what to do – when to tell people and how to talk to people was really difficult.”

   Alex immediately began antiretroviral treatment, initially taking four pills a day, which was reduced to one pill once his viral load came down to undetectable levels several months later. The latest results confirm that for the past nine years, he has not been able to transmit the virus to anyone, although at the time, medical advice was less definitive.

   Between his diagnosis and now, Alex spent six-and-a-half years in a relationship, and said the possibility – however tiny – of transmitting HIV to his partner was a source of anxiety. “You’d be told it was very unlikely, or that it was only possible under certain circumstances like having an STI,” he said. “But you’re constantly worried about these caveats and you go through this worry together. Now we can say zero risk, which is just so much more empowering for people. It’s a huge weight off your shoulders.”

   Alex hopes the findings will help transform public attitudes about HIV, bringing them in line with medical evidence. “A lot of stigma is driven by fear of being exposed to HIV,” he said. “People still think you can get it from kissing and casual contact. If more people knew about this study, this would change.”

Research Highlights: New Insecticide Resistance Mechanism in Mosquitoes

1. Date: December 26, 2019
2. Reviewed By: James Ives, M.Psych. (Editor)
3. Institution: Liverpool School of Tropical Medicine (LSTM)
4. Discovery: Identification of a new mechanism of insecticide resistance in malaria-carrying mosquitoes.
5. Species Studied:
   • Anopheles gambiae
   • Anopheles coluzzii
6. Key Finding: A particular family of binding proteins in the insect's legs is highly expressed in resistant populations.
7. Protein Identified: SAP2
   • Elevated in resistant populations.
   • Further increased following contact with pyrethroids (the insecticide used on bed nets).
   • Reduction of SAP2 levels restores susceptibility to pyrethroids.
   • Elevated levels of SAP2 induce resistance to pyrethroids in previously susceptible mosquitoes.
8. Implications:
   • Potential target for future additives to bed nets to overcome resistance.
   • Discovery of new resistance mechanisms highlights the need for identifying additional synergists to restore susceptibility.
9. Current Interventions: Introduction of new insecticide-treated bed nets containing piperonyl butoxide (PBO) in addition to pyrethroids.
   • PBO targets one of the most potent resistance mechanisms caused by cytochrome P450s.
10. Quote from Dr. Victoria Ingham: "We have found a completely new insecticide resistance mechanism that we think is contributing to the lower than expected efficacy of bed nets. The protein, which is based in the legs, comes into direct contact with the insecticide as the insect lands on the net, making it an excellent potential target for future additives to nets to overcome this potent resistance mechanism."
11. Quote from Professor Hilary Ranson: "Long-lasting insecticide treated bed nets remain one of the key interventions in malaria control. It is vital that we understand and mitigate for resistance within mosquito populations in order to ensure that the dramatic reductions in disease rates in previous decades are not reversed. This newly discovered resistance mechanism could provide us with an important target for both the monitoring of insecticide resistance and the development of novel compounds able to block pyrethroid resistance and prevent the spread of malaria."

1. Year: 2020
2. Research Focus: Link between severe COVID-19 cases and genetic mutations or auto-antibodies that attack the body.
3. Key Findings:
   • Some life-threatening COVID-19 cases are traced to weak spots in patients' immune systems.
   • At least 3.5% of study patients with severe COVID-19 have mutations in genes involved in antiviral defense.
   • At least 10% of patients with severe COVID-19 produce "auto-antibodies" that attack their own immune system, instead of fighting the virus.
   • Results published in Science on September 24, 2020.
   • 101 out of 987 patients with severe COVID-19 had these harmful auto-antibodies.
4. Implications:
   • Immediate implications for diagnostics and treatment.
   • Testing for auto-antibodies is recommended for patients who test positive for COVID-19.
   • Removing these antibodies from the blood could potentially ease symptoms of the disease.
5. Quote from Jean-Laurent Casanova: "Seeing these harmful antibodies in so many patients was a stunning observation. These two papers provide the first explanation for why COVID-19 can be so severe in some people, while most others infected by the same virus are okay."

Global Efforts in COVID-19 Research

1. Initial Study Start: February
2. Research Team: Casanova's team, in collaboration with global clinicians
3. Study Focus: Investigating severe COVID-19 cases in young people to identify underlying immune system weaknesses.
4. Genomic Analysis Plan:
   • Scan patients' genomes, focusing on 13 genes involved in interferon immunity against influenza.
   • Interferon molecules act as the body’s defense system, detecting and responding to viruses and bacteria.
   • Previous discoveries showed mutations hindering interferon production and function, increasing vulnerability to pathogens.
5. Study Progress:
   • Initial goal: Enroll 500 patients with severe COVID-19 worldwide.
   • By August, over 1,500 patients were enrolled; now more than 3,000.
   • Found harmful mutations in 23 out of 659 patients, affecting antiviral interferons.
6. Key Findings:
   • Some patients with severe COVID-19 have auto-antibodies that attack interferon proteins.
   • 101 out of 987 patients with life-threatening COVID-19 had these auto-antibodies.
   • These antibodies block interferon action and were absent in patients with mild COVID-19 cases.
7. Gender Findings:
   • 94% of patients with harmful auto-antibodies were men.
   • This finding offers an explanation for why men are more likely to develop severe COVID-19.
8. Future Research Directions:
   • Investigate the genetic driver behind the auto-antibodies, potentially linked to X chromosome mutations.
   • Explore clinical trials to test treatments such as interferons not neutralized by the auto-antibodies or plasmapheresis to remove harmful antibodies.
9. Additional Global Efforts:
   • The COVID Human Genetic Effort is looking for genetic factors that might be protective against COVID-19.
   • Recruiting people from households of patients with severe COVID-19 who were exposed but did not develop the disease.
   • "Our lab is currently running at full speed," says Casanova.

Teaching Hours Allotted to Human Biochemistry

Biochemistry	Hours
Lectures	81
Practical	52
Tutorial	32
Lecture Demonstrations (LD)	36
Small Group Teaching (SGT)	26
AETCOM	5
Self-Directed Learning (SDL)	20
Educational and Clinical Exposure (ECE)	30
Students Seminar	2/year

Post Graduate (MD)

Activity	Details
Lectures	82 per year
Journal Club	10 per year
Special Topic Presentation	10 per year
Microteaching Sessions	10 per year
PG Practical	Twice per week
Seminars	2 per term

Integration

The knowledge acquired in biochemistry shall help the students to integrate molecular events with the structure and function of the human body in health and disease.

A total of 38 lectures for Biochemistry are integrated with the following subjects:

• Anatomy
• Physiology
• Pathology
• General Medicine
• OBGY (Obstetrics and Gynecology)
• Pediatrics
• Microbiology

Horizontal Integrated Teaching

Sr. No	Topic	Competency	Name of the Department	Name of the Faculty	Date
1	Thyroid Gland	BI 6.14	Anatomy, Physiology, Biochemistry	Dr. A. D. Deshmukh	04/11/2022
2	Coronary Circulation & Applied Aspects	BI 12.5 to BI 12.7	Anatomy, Physiology, Biochemistry	Dr. Abhijit Pratap	25/04/2023

Organized by Department (Yearwise)

Sr. No.	Title	Date	Guest Speaker	No. of Delegates Attended
1	Newborn Screening	06/04/2015	Dr. Pramod Ingle	200
2	PG Quiz conducted in 3rd Maharashtra State Chapter Conference of Association of Medical Biochemists of India at Bharati Vidyapeeth Deemed University Medical College Pune	28th to 29th April 2017	-	300
3	PG Quiz conducted in 4th Maharashtra State Chapter Conference of Association of Medical Biochemists of India at Krishna Institute of Medical Sciences, “Deemed To Be University, Karad	1st - 2nd March 2019	-	300
4	Lipoprotein Metabolism & Disorders - A Biochemist’s Perspective	03/09/2021	Dr. C. Shanmugapriya	250

Conferences/CME/Workshop attended by faculty and students year wise (calendar year) from 1st 2014 to 2019 till date

Sr. No	Name of the Participant	Designation	Name of the CME/Conference/Workshop	Date & Venue/Place	Role
1	Dr. M. A. Tilak	Prof. Head	Basic Course workshop in Medical Education Technologies	27/01/14 to 29/01/14, Dr. D. Y. Patil Medical College, Pimpri, Pune	Delegate
2	Dr. V. V. Dhat	Prof.	Basic Course workshop in Medical Education Technologies	11/02/14 to 13/02/14, Dr. D. Y. Patil Medical College, Pimpri, Pune	Delegate
3	Dr. Abhijit Pratap	Asst. Prof.	Quality Conclave	15/04/14 to 16/04/14, New Delhi	Delegate
4	Dr. M. A. Tilak	Prof. Head	40th Annual Conference of Research Society of BJMC SGH	06/03/14 to 07/03/14, Pune	Delegate
5	Dr. M. A. Tilak	Prof. Head	AMBI – BIOCON 14 State Conference	05/04/14 to 06/04/14, Aurangabad	Delegate
6	Dr. Shilpa Joshi	Asst. Prof.	CME in Biochemistry	05/04/14, Deenanath Mangeshkar Hospital, Erandwane, Pune	Delegate
7	Dr. R. D. Naoley	Prof.	Basic Course Workshop in Medical Education Technologies	16/10/14 to 18/10/14, Dr. D. Y. Patil Medical College, Pimpri, Pune	Delegate
8	Dr. A. D. Deshmukh, Dr. Shilpa Joshi	Asso. Prof.	22nd AMBICON	14/11/14 to 16/11/14, Tirupati (Andhra Pradesh)	Delegate
9	Dr. Sandesh Thorat	Asst. Prof.	3rd Annual Research Society Conference 2014	27/11/14, MAEER’S MIMER Medical College, Talegaon Dabhade	Delegate
10	Dr. M. A. Tilak	Prof. & Head	International Multifocal Conference, 2014	04/12/14, Karad	Delegate
11	Dr. Sandesh Thorat	Asst. Prof.	340th Annual Conference of Research Society of B.J Government Medical College and Sassoon General Hospital, Pune	06/03/14 to 07/03/14, Pune	Delegate
12	Dr. M. A. Tilak	Prof. & Head	41st Annual Conference of Research Society	12/02/15 to 13/02/15, B. J. Medical College & Sassoon General Hospital, Pune	Delegate
13	Dr. M. A. Tilak	Prof. & Head	2nd Maharashtra State Chapter Conference AMBI-BIOCON 2015	27/02/15 to 28/02/15, LTMMC, Sion, Mumbai	Delegate
14	Dr. Ishita Ghatak	PG Student	Participated in PG Quiz at 2nd Maharashtra State Chapter Conference AMBI-BIOCON 2015	27/02/15 to 28/02/15, LTMMC, Sion, Mumbai	Delegate
15	Dr. M. A. Tilak	Prof. & Head	CME in Psychiatric Neuroscience	10/06/15 to 11/06/15, Dr. D. Y. Patil Medical College, Pune	Delegate
16	Dr. Abhijit Pratap	Asst. Prof.	Basic MET Workshop	28/07/15 to 30/07/15, Dr. D. Y. Patil Medical College, Pimpri	Delegate
17	Dr. S. A. Shinde	Asso. Prof.	3T Bioethics Training Program Workshop, for Medical Teachers	03/08/15 to 06/08/15, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune	Delegate
18	Dr. V. V. Dhat	Prof.	Internal Auditors Training as per ISO 9001-2008	07/08/15 to 08/08/15, Dr. D. Y. Patil Dental College, Pimpri, Pune	Delegate
19	Dr. Abhijit Pratap	Asst. Prof.	6th East Zone Conference of Association of Clinical Biochemists of India	26/09/15 to 27/09/15, Bokaro Steel City, Jharkhand	Delegate
20	Dr. Sandesh Thorat	Asst. Prof.	41st Annual Conference of Research Society of B.J Government Medical College and Sassoon General Hospital, Pune	12/02/15 to 13/02/15, Pune	Delegate
21	Dr. M. A. Tilak	Prof. & Head	42nd Annual Conference	24/02/16 to 26/02/16, The Research Society of B. J. Government Medical College and Sassoon General Hospitals, Pune	Delegate
22	Dr. S. A. Shinde	Asso. Prof.	Women’s Health A Holistic Approach	08/03/16 to 13/03/16, Dr. D. Y. Patil Vidyapeeth, Pune	Delegate
23	Dr. M. A. Tilak	Prof. & Head	National Seminar on Web Scale Discovery Service-A New Avatar in Medical Information Retrieval	04/04/16, AIIMS, New Delhi	Delegate
24	Dr. P. J. Phalak	Asso. Prof.	3T Bioethics Training Program Workshop, for Medical Teachers	04/04/16 to 06/04/16, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune	Delegate
25	Dr. Abhijit Pratap	Asst. Prof.	Flow Cytometry Workshop	12/03/16, Dr. D. Y. Patil Medical College, Pimpri	Delegate
26	Dr. Abhijit Pratap	Asst. Prof.	3rd APPI Conference	11/06/16 to 12/06/16, Mumbai	Delegate
27	Dr. Lalna Takale	Asst. Prof.	Fourth Scientist Research Conference	28/07/16 to 29/07/16, IISER, Pune	Delegate
28	Dr. Abhijit Pratap	Asst. Prof.	PATHOCON	18/12/16, New Delhi	Delegate
29	Dr. Abhijit Pratap	Asst. Prof.	HPLC Workshop	17/12/16, New Delhi	Delegate
30	Dr. Jayita Debnath	PG Student	Workshop on Research Methodology for Residents	17/06/16 to 28/06/16, Dr. D. Y. Patil Medical College, Pimpri	Delegate
31	Dr. Jayita Debnath	PG Student	Workshop on Bioethics and Professionalism	17/08/16, Dr. D. Y. Patil Vidyapeeth, Pune	Delegate
32	Dr. Jayita Debnath	PG Student	Workshop on Microteaching for Residents/Demonstrators	27/09/16 to 28/09/16 and 04/10/16, Dr. D. Y. Patil Medical College, Pimpri	Delegate
33	Dr. Sandesh Thorat	Asst. Prof.	Quality Management System and Internal Audit in Medical Laboratories as per ISO 15189:2012 - Medical Education and Learning Point	22/06/16 to 25/06/16, Bharati Vidyapeeth Deemed University Medical College, Pune	Delegate
34	Dr. P. J. Phalak	Asso. Prof.	Revised Basic Course Workshop in Medical Education Technologies	03/01/17 to 05/01/17, DYPMC, Pimpri	Delegate
35	Dr. M. A. Tilak	Prof. & Head	43rd Annual Conference	21/02/17 to 23/02/17, B. J. Govt. Medical College and Sassoon General Hospitals, Pune	Delegate
36	Dr. R. D. Naoley	Prof.	Midterm National Conference of Geriatric Society of India	15/04/17 to 16/04/17, Dr. D. Y. Patil Medical College, Pimpri	Delegate
37	Dr. M. A. Tilak	Prof. & Head	3rd Maharashtra State Chapter Conference of Association of Medical Biochemists of India	28/04/17 to 29/04/17, Bharati Vidyapeeth, Pune	Delegate
38	Dr. Abhijit Pratap	Asst. Prof.	44th National Conference of Association of Clinical Biochemists of India	03/12/17 to 06/12/17, Scientific Convention Centre, KGMU, Lucknow	Delegate
39	Dr. Sarita Shinde	Prof.	Workshop on Research Methodology	04/08/18, Dr. D. Y. Patil Vidyapeeth, Pune	Delegate
40	Dr. M. A. Tilak	Prof. & Head	Latest Trends in Quality Control	28/09/18, BioRad Laboratories, Sheraton Grand, Pune	Delegate
41	Dr. Abhijit Pratap	Asst. Prof.	45th National Conference of Association of Clinical Biochemists of India	24/10/18 to 27/10/18, Kala Academy, Goa	Delegate
42	Dr. M. A. Tilak	Prof. & Head	AMBICON 4th Maharashtra State Chapter Conference of Association of Medical Biochemists of India	01/03/19 to 02/03/19, Karad	Delegate
43	Dr. Vaishali Dhat	Prof.	Curriculum Implementation Support Programme	22/04/19 to 24/04/19, Dr. D. Y. Patil Medical College, Pimpri	Delegate
44	Dr. U. K. More	Prof.	CME on Quality Control and Chromatogram Interpretation	06/06/19, Bio-Rad Laboratories, Pune	Delegate
45	Dr. Sandesh Thorat	Asst. Prof.	MCI Revised Basic and AETCOM Workshop in Medical Education Technology (MET)	24/09/19 to 27/09/19, Dr. D. Y. Patil Medical College, Pimpri, Pune	Delegate

2020

#	Name of the CME/Conference/Workshop	Date	Place	Name of the Participant
1	Challenges to Reach Nutritional Adequacy-Public Health Significance and Autoimmune Disorders	18th-19th Jan. 2020	Association of Clinical Biochemists of India (ACBI) & Department of Pathology, LMMF’S Deenanath Mangeshkar Hospital & Research Center, Pune	Dr. U. K. More, Dr. P. J. Phalak
2	9th Annual International Conference of Indian Academy of Biomedical Sciences	27th-29th Feb. 2020	Department of Biochemistry Dr. Y Patil Medical College, Kolhapur	Dr. U. K. More

2021

#	Name of the CME/Conference/Workshop	Date	Place	Name of the Participant
1	Outcome analysis workshop	22/10/21	Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
2	(Online Workshop) Newer Assessment Methods	1st November 2021	Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Anita Deshmukh
3	(E-Conference) 28th National conference of Association of Medical Biochemists of India	2nd-5th December 2021	(Virtual Conference) Department of Biochemistry, AIIMS Raipur	Dr. Vaishali Dhat
4	(E-Conference) 28th National conference of Association of Medical Biochemists of India	2nd-5th December 2021	(Virtual Conference) Department of Biochemistry, AIIMS Raipur	Dr. Pradnya Phalak
5	(E-Conference) 47th National Conference of Association of Clinical Biochemists of India (ACBCON)	12th-15th December 2021	(Virtual Conference) Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
6	(Online) Basic Course in Biomedical Research	Mar-Jun-2021	Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sandesh Thorat
7	The National Institute of Health & Family Welfare (Health Care Communication)	15th-17th December 2021	Online Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
8	Journal of Pharmaceutical Research International certificate of Excellence in Reviewing	8th Feb 2022	Online Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
9	All India Institute of Medical Science, Rajkot Symposium – Cellular & Molecular Biomarkers	14th May 2022	Online Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
10	Workshop IMPACT 2022 ‘Scientific Writing & Reviewing’	15th-17th Sep. 2022	Online Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak

2022

#	Name of the CME/Conference/Workshop	Date	Place	Name of the Participant
1	CME ON Artificial Intelligence – Role in Health Care & Clinical Diagnostics	16th September 2022	MVJ Medical College & Research Hospital, Bangalore	Dr. Umesh More, Dr. Sarita Shinde, Dr. Pradnya Phalak, Dr. Anita Deshmukh
2	Research Publication Workshop	14th -15th Oct. 2022	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
3	CME : Advancement in Laboratory Sciences	18/11/2022	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
4	Conference : 48th Annual Conference of ACBI	24th to 26th Nov. 2022	New Delhi, India	Dr. Abhijit Pratap
5	Journal of Pharmaceutical Research International Certificate of Excellence in Reviewing	9th Feb 2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
6	Asian Journal of Medicine and Health	5th May 2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
7	International Journal of Biochemistry Research & Review	12th April 2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
8	Association of Medical Biochemists of India (AMBI)	25/04/2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
9	Basic Course in Biomedical Research	April 2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Shilpa Joshi
10	International CME - Biochemistry Aspects of Yoga	21/06/2023	Online, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Umesh More, Dr. Shilpa Joshi, Dr. Pradnya Phalak, Dr. Anita Deshmukh, Mrs. Madhuri Jagtap, Mrs. Nidhi Purandare, Dr. Astha Goyal

2023

Sr. No.	Name of the CME/Conference/Workshop	Date	Place	Name of the Participant
1	CME – Unmasking the Unknown in ID	24/06/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak
2	CME- Laboratory Errors	30/06/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Umesh More, Dr. Pradnya Phalak, Dr. Shilpa Joshi, Dr. Astha Goyal
3	Webinar – Implementation of New Standards in Medical Laboratories	07/07/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Shilpa Joshi
4	Webinar- Automation in Bioprocessing National Webinar	19/07/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Shilpa Joshi
5	CME- Lets Decode ABG	03/08/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde, Dr. Pradnya Phalak, Dr. Shilpa Joshi
6	MGMIHS-RESEARCH MELA NIRCON-23 National Interdisciplinary Research Conference	02/09/2023 & 03/09/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak, Dr. Shilpa Joshi, Dr. Sandesh Thorat
7	Webinar- Hemoglobin Variants- A Case Based Approach	13/09/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Shilpa Joshi
8	49th ACBICON 2023 KERALA	14th to 16th September 2023	AI Saj Convention Centre, Kazhakkottam, Trivandrum	Dr. Shilpa Joshi, Mrs. Madhuri Jagtap
9	FLUOROSIS : AN OVERVIEW National Webinar	11/10/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak, Dr. Shilpa Joshi
10	International Best Researcher Award	28/10/2023	Hotel Breeze Residency, India	Dr. Sandesh Thorat
11	National Webinar Inborn Errors of Metabolism in the –OMICS era	11/12/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Sarita Shinde
12	CME Diagnostic Diversity of Markers in Oncology : An Update	20/12/2023	Online, Dr.D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune	Dr. Pradnya Phalak, Dr. Anita Deshmukh, Dr. Arti Hajarnavis, Dr. Shilpa Joshi